Inventor · disambiguated record
Patrice Cacoub
Also filed as: CACOUB PATRICE
7 granted patents·2 pending applications·42 citations·filing 2012–2023
81Inventor score
Files withINST NAT SANTE RECH MED4BIOPREDICTIVE1CENTRE NAT RECH SCIENT1HOPITAUX PARIS ASSIST PUBLIQUE1ILTOO PHARMA1
Top patents by PatentIndex Score
9 records- 0194US10293028B2Use of low dose IL-2 for treating autoimmune related or inflammatory disordersINST NAT SANTE RECH MED·Filed 2017·Granted May 21, 2019·23 cites·20 claims
- 0288US9669071B2Method for stimulating T lymphocytes with IL-2KLATZMANN DAVID·Filed 2012·Granted Jun 6, 2017·13 cites·18 claims
- 0387US10765723B2Use of low dose IL-2 for treating autoimmune—related or inflammatory disordersINST NAT SANTE RECH MED·Filed 2019·Granted Sep 8, 2020·5 cites·10 claims
- 0484US11559566B2Use of low dose IL-2 for treating autoimmune-related or inflammatory disordersINST NAT SANTE RECH MED·Filed 2020·Granted Jan 24, 2023·1 cites·16 claims
- 0567US12491232B2Low dose IL-2 for treating autoimmune-related or inflammatory disordersINST NAT SANTE RECH MED·Filed 2023·Granted Dec 9, 2025·0 cites·18 claims
- 0648US12487243B2Method of diagnosis of infection by the SARS-CoV-2 virusBIOPREDICTIVE·Filed 2021·Granted Dec 2, 2025·0 cites·5 claims
- 0746US11534479B2Use of interleukin 2 for treating Sjögren's syndromeILTOO PHARMA·Filed 2019·Granted Dec 27, 2022·0 cites·14 claims
- 0838US2014236621A1Method for determining a predictive function for discriminating patients according to their disease activity statusCENTRE NAT RECH SCIENT·Filed 2012·Application pending·0 cites
- 0930US2019060407A1Use of interleukin 2 for treating spondyloarthritisHOPITAUX PARIS ASSIST PUBLIQUE·Filed 2016·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →